| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.91B | 92.42B | 90.93B | 93.66B | 86.33B | 109.37B |
| Gross Profit | 20.53B | 20.82B | 20.66B | 15.43B | 16.83B | 15.66B |
| EBITDA | 11.35B | 11.61B | 10.63B | 8.34B | 6.78B | 8.31B |
| Net Income | 3.09B | 3.26B | 2.72B | -2.01B | -1.23B | -368.00M |
Balance Sheet | ||||||
| Total Assets | 134.83B | 132.32B | 134.05B | 131.78B | 145.39B | 146.74B |
| Cash, Cash Equivalents and Short-Term Investments | 10.30B | 13.37B | 12.80B | 10.16B | 10.07B | 8.43B |
| Total Debt | 42.59B | 43.10B | 43.42B | 43.02B | 55.43B | 61.60B |
| Total Liabilities | 72.21B | 70.09B | 73.18B | 76.89B | 88.36B | 89.52B |
| Stockholders Equity | 58.01B | 57.49B | 56.05B | 50.59B | 52.97B | 53.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.19B | 3.19B | 5.50B | 3.71B | -839.00M |
| Operating Cash Flow | 0.00 | 12.50B | 7.36B | 9.29B | 11.86B | 3.97B |
| Investing Cash Flow | 0.00 | -10.15B | -3.85B | 4.09B | -3.60B | -5.58B |
| Financing Cash Flow | 0.00 | -1.76B | -1.23B | -13.43B | -7.21B | 3.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥488.91B | 10.13 | 6.90% | 2.71% | -0.06% | 137.47% | |
77 Outperform | ¥103.33B | 7.99 | 7.53% | 3.01% | 5.44% | 45.99% | |
76 Outperform | ¥27.70B | -17.25 | ― | 4.32% | -1.28% | 30.53% | |
74 Outperform | ¥79.37B | 12.05 | ― | 6.64% | 2.85% | -9.13% | |
73 Outperform | ¥57.64B | 5.78 | ― | 3.31% | 0.83% | -9.16% | |
70 Outperform | ¥147.56B | 4.25 | 10.46% | 2.35% | 4.56% | 49.23% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |